Cepheid Inc - Company Profile
Powered by 
All the sales intelligence you need on Cepheid Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cepheid Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cepheid Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care-associated infections, critical infectious diseases, sexual health, virology, oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products directly and through a network of distributors present across the Americas, Asia, Europe, Africa, and the Middle East. The company also offers various services such as maintenance, software updates, repair, and support among others. Cepheid is headquartered in Sunnyvale, California, the US.
Headquarters
United States of America
Address
904 Caribbean Drive, Sunnyvale, California, 94089
Website
www.cepheid.com
Telephone
1 888 8383222
Industry
Medical Equipment
Cepheid Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Healthcare Associated Infections: | Maintenance | Cartridge |
| Xpert MRSA NxG | Support | Cepheid |
| Xpert MRSA/SA SSTI | Repair | SmartCycler |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In April, the company expanded its partnership with Oxford Nanopore to develop a workflow for rapid bacterial and fungal pathogen identification. |
| 2026 | Regulatory Approval | In January, the company received FDA clearance for Xpert GI panel to support broad detection of gastrointestinal pathogens. |
| 2025 | Regulatory Approval | In August, the company received Health Canada license for Xpert HCV VL Fingerstick. |
Competitor Comparison
| Key Parameters | Cepheid Inc | Hologic Inc | GenMark Diagnostics Inc | Binx Health Inc | Luminex Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Sunnyvale | Marlborough | Carlsbad | Cambridge | Austin |
| State/Province | California | Massachusetts | California | Massachusetts | Texas |
| No. of Employees | - | 7,070 | - | - | - |
| Entity Type | Private | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Charles Mwangi | Chief Financial Officer; Senior Vice President | Senior Management | 2023 | - |
| Connie Savor, M.D. | Chief Medical Officer | Senior Management | - | - |
| Traci Wicks | Senior Vice President - Human Resources | Senior Management | - | - |
| Nichole Halsey | Vice President - Global Danaher Business System Leader | Senior Management | - | - |
| Luben Li | Senior Vice President - Global Product Management & Marketing | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer